MedTrace Logo

Imaging the Uterine Cervix - UltraSightHD™

NCT01090635 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12

Last updated 2011-02-04

No results posted yet for this study

Summary

The purpose of this study is to investigate the performance ability of the UltraSightHD™. The instrument will be assessed on characteristics such as focus quality, ability to image the entire cervix, and illumination. The information gathered from this study will provide data that will be used to determine which settings provide the best imaging outcome for the cervix for a simple screening instrument. Further, this information will serve as the foundation in the development of more advanced follow-on imaging devices.

The primary objectives of this study are to:

* Determine if the light source provides sufficient illumination of the cervix.
* Assess focus and overall image quality.
* Assess the functionality and ergonomics of the instrument's design.

Conditions

  • Uterine Cervical Neoplasms

Sponsors & Collaborators

  • STI-Medical Systems

    lead INDUSTRY

Principal Investigators

  • Nathan Fujita, M.D.

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2011-02-28
Completion
2011-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01090635 on ClinicalTrials.gov